{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:24:26Z","timestamp":1784823866337,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.resinv.2019.01.009","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T09:49:28Z","timestamp":1551174568000},"page":"213-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Pneumocystis pneumonia in HIV-1-infected patients"],"prefix":"10.1016","volume":"57","author":[{"given":"Satoshi","family":"Shibata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2019.01.009_bib1","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1001\/jama.286.19.2450","article-title":"New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia","volume":"286","author":"Kovacs","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.resinv.2019.01.009_bib2","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1001\/jama.2009.880","article-title":"Evolving health effects of pneumocystis: one hundred years of progress in diagnosis and treatment","volume":"301","author":"Kovacs","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.resinv.2019.01.009_bib3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/334519a0","article-title":"Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi","volume":"334","author":"Edman","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.resinv.2019.01.009_bib4","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1086\/498158","article-title":"Has the name really been changed? It has for most researchers","volume":"41","author":"Cushion","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2019.01.009_bib5","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJM198112103052401","article-title":"Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency","volume":"305","author":"Gottlieb","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2019.01.009_bib6","first-page":"466","article-title":"Projecting the medical costs of AIDS and ARC in the United States","volume":"1","author":"Hay","year":"1988","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.resinv.2019.01.009_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1542\/peds.61.1.35","article-title":"Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children","volume":"61","author":"Pifer","year":"1978","journal-title":"Pediatrics"},{"key":"10.1016\/j.resinv.2019.01.009_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/649868","article-title":"Pneumocystis colonization is highly prevalent in the autopsied lungs of the general population","volume":"50","author":"Ponce","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2019.01.009_bib9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.transproceed.2008.10.027","article-title":"Cluster outbreak of Pneumocystis pneumonia among kidney transplant patients within a single center","volume":"41","author":"Arichi","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.resinv.2019.01.009_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2217\/fmb.09.116","article-title":"Current understanding of Pneumocystis immunology","volume":"5","author":"Kelly","year":"2010","journal-title":"Future Microbiol"},{"key":"10.1016\/j.resinv.2019.01.009_bib11","first-page":"29","article-title":"Pneumocystis jirovecii pneumonia in rheumatoid arthritis patients: risks and prophylaxis recommendations","volume":"9","author":"Mori","year":"2015","journal-title":"Clin Med Insights Circ Respir Pulm Med"},{"key":"10.1016\/j.resinv.2019.01.009_bib12","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/TP.0b013e3181aed389","article-title":"Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients: p. jiroveci is contagious to the susceptible host","volume":"88","author":"Yazaki","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.resinv.2019.01.009_bib13","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.3201\/eid1010.030994","article-title":"Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance","volume":"10","author":"Huang","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.resinv.2019.01.009_bib14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1086\/653933","article-title":"Quantification and spread of Pneumocystis jirovecii in the surrounding air of patients with Pneumocystis pneumonia","volume":"51","author":"Choukri","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2019.01.009_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/1753465810380102","article-title":"Update on the diagnosis and treatment of Pneumocystis pneumonia","volume":"5","author":"Carmona","year":"2011","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.resinv.2019.01.009_bib16","first-page":"39","article-title":"Shortcomings of chest radiography in detecting Pneumocystis carinii pneumonia","volume":"7","author":"Opravil","year":"1994","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.resinv.2019.01.009_bib17","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2214\/ajr.169.4.9308446","article-title":"High-resolution CT in the evaluation of clinically suspected Pneumocystis carinii pneumonia in AIDS patients with normal, equivocal, or nonspecific radiographic findings","volume":"169","author":"Gruden","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.resinv.2019.01.009_bib18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1378\/chest.108.2.415","article-title":"Serum lactate dehydrogenase (LDH) in Pneumocystis carinii pneumonia, tuberculosis, and bacterial pneumonia","volume":"108","author":"Quist","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2019.01.009_bib19","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1164\/ajrccm\/137.4.796","article-title":"Serum lactate dehydrogenase levels and Pneumocystis carinii pneumonia. Diagnostic and prognostic significance","volume":"137","author":"Zaman","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.resinv.2019.01.009_bib20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1128\/cdli.3.2.197-199.1996","article-title":"(1-->3) beta-D-glucan as a quantitative serological marker for Pneumocystis carinii pneumonia","volume":"3","author":"Yasuoka","year":"1996","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.resinv.2019.01.009_bib21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/cid\/cir335","article-title":"Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia","volume":"53","author":"Sax","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2019.01.009_bib22","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1164\/ajrccm.165.3.2107134","article-title":"Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases","volume":"165","author":"Ohnishi","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2019.01.009_bib23","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2169\/internalmedicine.50.5296","article-title":"Kinetics of serum beta-D-glucan after Pneumocystis pneumonia treatment in patients with AIDS","volume":"50","author":"Koga","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2019.01.009_bib24","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1378\/chest.06-1467","article-title":"Serum indicators for the diagnosis of pneumocystis pneumonia","volume":"131","author":"Tasaka","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2019.01.009_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2169\/internalmedicine.48.1680","article-title":"Clinical utility of serum beta-D-glucan and KL-6 levels in Pneumocystis jirovecii pneumonia","volume":"48","author":"Nakamura","year":"2009","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2019.01.009_bib26","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1183\/09031936.02.01372002","article-title":"Meta-analysis of diagnostic procedures for Pneumocystis carinii pneumonia in HIV-1-infected patients","volume":"20","author":"Cruciani","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2019.01.009_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1378\/chest.90.1.18","article-title":"Bronchoalveolar lavage as the exclusive diagnostic modality for Pneumocystis carinii pneumonia. A prospective study among patients with acquired immunodeficiency syndrome","volume":"90","author":"Golden","year":"1986","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2019.01.009_bib28","first-page":"929","article-title":"The diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome using subsegmental bronchoalveolar lavage","volume":"129","author":"Ognibene","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.resinv.2019.01.009_bib29","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJM198803103181001","article-title":"Diagnosis of Pneumocystis carinii pneumonia: improved detection in sputum with use of monoclonal antibodies","volume":"318","author":"Kovacs","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2019.01.009_bib30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.femsim.2005.06.006","article-title":"Molecular diagnosis of Pneumocystis pneumonia","volume":"45","author":"Durand-Joly","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.resinv.2019.01.009_bib31","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1128\/JCM.03174-15","article-title":"Detection of Pneumocystis jirovecii by quantitative PCR to differentiate colonization and pneumonia in immunocompromised HIV-positive and HIV-negative patients","volume":"54","author":"Fauchier","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.resinv.2019.01.009_bib32","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1469-0691.2011.03605.x","article-title":"Quantitative real-time PCR and the (1-->3)-beta-D-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization","volume":"18","author":"Matsumura","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.resinv.2019.01.009_bib33","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1097\/00002030-200109280-00012","article-title":"Adult, Adolescent Spectrum of HIVDPI. Viral load as an independent risk factor for opportunistic infections in HIV-infected adults and adolescents","volume":"15","author":"Kaplan","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.resinv.2019.01.009_bib34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199001183220304","article-title":"The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group","volume":"322","author":"Phair","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2019.01.009_bib35","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1086\/655761","article-title":"Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells\/microL?","volume":"51","author":"Opportunistic Infections Project Team of the Collaboration of Observational HIVERiE","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2019.01.009_bib36","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199503163321101","article-title":"A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group","volume":"332","author":"Bozzette","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2019.01.009_bib37","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJM199212243272603","article-title":"A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group","volume":"327","author":"Schneider","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2019.01.009_bib38","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/infdis\/171.6.1632","article-title":"Efficacy and toxicity of two doses of trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus. Dutch AIDS Treatment Group","volume":"171","author":"Schneider","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.resinv.2019.01.009_bib39","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1086\/520433","article-title":"A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA)","volume":"29","author":"El-Sadr","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2019.01.009_bib40","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7326\/0003-4819-100-4-495","article-title":"Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome","volume":"100","author":"Gordin","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.resinv.2019.01.009_bib41","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1086\/323353","article-title":"Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ","volume":"184","author":"Leoung","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.resinv.2019.01.009_bib42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00042560-200008010-00007","article-title":"Reduced toxicity with gradual initiation of trimethoprim-sulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia: aids Clinical Trials Group 268","volume":"24","author":"Para","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.resinv.2019.01.009_bib43","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1086\/314893","article-title":"Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides","volume":"180","author":"Chan","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.resinv.2019.01.009_bib44","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJM199812243392604","article-title":"Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group","volume":"339","author":"El-Sadr","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2019.01.009_bib45","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJM199212243272604","article-title":"A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021","volume":"327","author":"Hardy","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2019.01.009_bib46","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJM199305273282103","article-title":"Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS","volume":"328","author":"Hughes","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2019.01.009_bib47","doi-asserted-by":"crossref","first-page":"792","DOI":"10.7326\/0003-4819-124-9-199605010-00003","volume":"124","author":"Safrin","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.resinv.2019.01.009_bib48","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1056\/NEJM199009203231202","article-title":"Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone","volume":"323","author":"Medina","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2019.01.009_bib49","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/clinids\/18.6.905","article-title":"Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS: aids Clinical Trials Group 044","volume":"18","author":"Black","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2019.01.009_bib50","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1001\/archinte.161.12.1529","article-title":"A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia","volume":"161","author":"Smego","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.resinv.2019.01.009_bib51","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1086\/514696","article-title":"Clindamycin with primaquine vs. Trimethoprim-sulfamethoxazole therapy for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS: a multicenter, double-blind, randomized trial (CTN 004). CTN-PCP Study Group","volume":"27","author":"Toma","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2019.01.009_bib52","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-109-4-280","article-title":"Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study","volume":"109","author":"Sattler","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.resinv.2019.01.009_bib53","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/thx.2010.135350","article-title":"A trial of caspofungin salvage treatment in PCP pneumonia","volume":"66","author":"Armstrong-James","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2019.01.009_bib54","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJM199011223232131","article-title":"Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome","volume":"323","author":"National Institutes of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis P","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2019.01.009_bib55","doi-asserted-by":"crossref","first-page":"e0138926","DOI":"10.1371\/journal.pone.0138926","article-title":"A 21-day of adjunctive corticosteroid use may not be necessary for hiv-1-infected Pneumocystis pneumonia with moderate and severe disease","volume":"10","author":"Shibata","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2019.01.009_bib56","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJM199011223232104","article-title":"A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group","volume":"323","author":"Bozzette","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2019.01.009_bib57","doi-asserted-by":"crossref","first-page":"14","DOI":"10.7326\/0003-4819-113-1-14","article-title":"Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS)","volume":"113","author":"Montaner","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.resinv.2019.01.009_bib58","first-page":"726","article-title":"Adjunctive corticosteroid therapy for Pneumocystis carinii pneumonia in AIDS: a randomized European multicenter open label study","volume":"5","author":"Nielsen","year":"1992","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.resinv.2019.01.009_bib59","unstructured":"Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents:recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America, \u3008http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adult_oi.pdf\u3009; 2018 [Accessed 27 October 2018]."},{"key":"10.1016\/j.resinv.2019.01.009_bib60","doi-asserted-by":"crossref","first-page":"e5575","DOI":"10.1371\/journal.pone.0005575","article-title":"Early antiretroviral therapy reduces AIDS progression\/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial","volume":"4","author":"Zolopa","year":"2009","journal-title":"PLoS One"}],"updated-by":[{"DOI":"10.1016\/j.resinv.2020.09.004","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000}}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534518302223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534518302223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:29:42Z","timestamp":1761949782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534518302223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S2212534518302223"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2019.01.009","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pneumocystis pneumonia in HIV-1-infected patients","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2019.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V. on behalf of The Japanese Respiratory Society","name":"copyright","label":"Copyright"}]}}